ATE400280T1 - Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms - Google Patents

Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms

Info

Publication number
ATE400280T1
ATE400280T1 AT03816391T AT03816391T ATE400280T1 AT E400280 T1 ATE400280 T1 AT E400280T1 AT 03816391 T AT03816391 T AT 03816391T AT 03816391 T AT03816391 T AT 03816391T AT E400280 T1 ATE400280 T1 AT E400280T1
Authority
AT
Austria
Prior art keywords
iron
restle
administration
treatment
composition
Prior art date
Application number
AT03816391T
Other languages
English (en)
Inventor
Mary Jane Helenek
Ralf Lange
Fred Oldham
Marc Tokars
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Application granted granted Critical
Publication of ATE400280T1 publication Critical patent/ATE400280T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
AT03816391T 2003-03-14 2003-05-13 Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms ATE400280T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome

Publications (1)

Publication Number Publication Date
ATE400280T1 true ATE400280T1 (de) 2008-07-15

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03816391T ATE400280T1 (de) 2003-03-14 2003-05-13 Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms

Country Status (25)

Country Link
US (1) US6960571B2 (de)
EP (1) EP1603580B1 (de)
JP (2) JP2006520322A (de)
KR (1) KR100978377B1 (de)
CN (1) CN1771044B (de)
AT (1) ATE400280T1 (de)
AU (1) AU2003249635C1 (de)
BR (1) BR0318185A (de)
CA (1) CA2518971C (de)
CY (1) CY1110407T1 (de)
DE (1) DE60322121D1 (de)
DK (1) DK1603580T3 (de)
ES (1) ES2309403T3 (de)
HR (1) HRP20050796A2 (de)
IL (1) IL170386A (de)
MX (1) MXPA05009786A (de)
NO (1) NO20054728L (de)
PL (1) PL206810B1 (de)
PT (1) PT1603580E (de)
RS (1) RS51823B (de)
RU (1) RU2319490C2 (de)
SI (1) SI1603580T1 (de)
UA (1) UA83483C2 (de)
WO (1) WO2004082693A1 (de)
ZA (1) ZA200508308B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (de) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Kontrastmittel Zusammensetzungen für die Bildgebung des Lymphsystems
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
KR20080078075A (ko) * 2005-12-20 2008-08-26 세레우사이언스 아베 하지 불안 증후군의 치료 및 진단을 위한 방법 및 조성물
CN102861336A (zh) * 2005-12-23 2013-01-09 阿贾伊·古普塔 含铁的肠胃外营养组合物
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
EP3081219A1 (de) 2006-01-06 2016-10-19 Luitpold Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur eisenverabreichung
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (de) * 2007-01-04 2008-07-09 Vifor (International) Ag Mehrkammerbeutel zur Lagerung von Eisenpräparaten
CA2719577C (en) * 2008-03-28 2016-11-22 Chyna Llc Use of ferritin to treat iron deficiency disorders
EP2296998A1 (de) * 2008-05-23 2011-03-23 Hospira, Inc. Verpackte eisensaccaroseprodukte
US20100160295A1 (en) * 2008-11-06 2010-06-24 Synosia Therapeutics Treatment of restless leg syndrome and sleep disorders
MX2011009936A (es) 2009-03-25 2011-10-06 Pharmacosmos Holding As Un compuesto de oligosacarido de hierro estable.
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
EP2968503B1 (de) 2013-03-15 2018-08-15 Intrinsic LifeSciences LLC Anti-hepcidin-antikörper und verwendungen davon
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
WO2016049036A1 (en) 2014-09-22 2016-03-31 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
WO2016069950A2 (en) * 2014-10-29 2016-05-06 University Of Utah Research Foundation Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)
EP2913054A1 (de) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Eisenkohlenhydratkomplex zur behandlung des restless-leg-syndroms (rls)
WO2023028252A1 (en) 2021-08-27 2023-03-02 American Regent, Inc. Iron compositions and methods of making and using them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248492A (en) * 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
RU2153351C2 (ru) * 1995-12-14 2000-07-27 Закрытое акционерное общество "ВАМ" Средство для регулирования эндогенной продукции цитокинов и гемопоэтических факторов (варианты) и способ его использования
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
AU2001251306A1 (en) 2000-04-04 2001-10-15 Siegel, Jerome M. Treatment of sleep disorders with hypocretin-1

Also Published As

Publication number Publication date
JP2006520322A (ja) 2006-09-07
CA2518971C (en) 2009-02-17
CN1771044A (zh) 2006-05-10
BR0318185A (pt) 2006-03-21
AU2003249635C1 (en) 2009-11-05
RS20050695A (sr) 2008-04-04
DE60322121D1 (de) 2008-08-21
IL170386A (en) 2013-03-24
ES2309403T3 (es) 2008-12-16
WO2004082693A1 (en) 2004-09-30
PT1603580E (pt) 2008-09-10
SI1603580T1 (sl) 2009-04-30
CY1110407T1 (el) 2015-04-29
EP1603580B1 (de) 2008-07-09
AU2003249635B2 (en) 2009-06-04
PL378875A1 (pl) 2006-05-29
US20040180849A1 (en) 2004-09-16
UA83483C2 (uk) 2008-07-25
ZA200508308B (en) 2006-10-25
HK1089666A1 (en) 2006-12-08
PL206810B1 (pl) 2010-09-30
NO20054728D0 (no) 2005-10-13
RU2005131832A (ru) 2006-03-20
HRP20050796A2 (en) 2005-12-31
CA2518971A1 (en) 2004-09-30
RU2319490C2 (ru) 2008-03-20
KR20060082032A (ko) 2006-07-14
US6960571B2 (en) 2005-11-01
EP1603580A1 (de) 2005-12-14
AU2003249635A1 (en) 2004-10-11
MXPA05009786A (es) 2006-03-08
JP2010180252A (ja) 2010-08-19
NO20054728L (no) 2005-12-13
CN1771044B (zh) 2012-09-19
DK1603580T3 (da) 2008-10-06
RS51823B (sr) 2012-02-29
KR100978377B1 (ko) 2010-08-30

Similar Documents

Publication Publication Date Title
DE60322121D1 (de) Zusammensetzung zur verabreichung von eisen für die behandlung des unruhigen beinsyndroms
EP1670450A4 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
DE60219595D1 (de) Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
ATE395052T1 (de) Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
SG155967A1 (en) Hcv ns3-ns4a protease inhibition
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
SE0401631D0 (sv) New Composition
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
PL1682162T3 (pl) Zastosowanie opuncji do leczenia depresyjnych rozstrojów i chorób
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DE502005006897D1 (de) 4-aminophenyl-morpholinon-derivate zur behandlung von hepatitis c
DE60308862D1 (de) Verbindungen und zusammensetzungen zur behandlung von diabetes und erkrankungen, die mit diabetes in zusammenhang stehen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1603580

Country of ref document: EP